Become A Member

Unani System of Medicine refers to Graeco-Arabic drug, which is established on the training of Greek physician Hippocrates and Roman physician Galen and developed into an elaborate medical system in middle age period by Arabian and Persian physicians, similar as Rhazes (al Razi), Avicenna (Ibn-e-Sina), Al-Zahrawi, and Ibn Nafis. Buqrat (more known as Hippocrates, 460-377 BC) is said to be a progeny of Aesculapius and honored as „ father of Unani drug'. It appeared in Greece nearly 2500 times back and has been using drugs of around 90 herbal, 4-5 animal and 5-6 mineral origin. It is not only the original knowledge of drug but also a rich store house of principles and philosophies of drug which can be of immense value to the drug in particular and knowledge in general. Diseases and complications are considered to derange the normal temperament and homeostasis of the humours in the body. So regimental remedy or (Ilaj bi ‟ l-Tadabeer) pharmacotherapy (Ilaj bi ‟ l-Dawa) have been used since ancient times as per the sole generalization to bring back the homeostasis of the humours and to correct the unusual temperament involved. Once this mode of treatment proved impotent, section (Ilaj bi ‟ l-yad) has been advised as a last resort.

Unani system of medicine, although began in Greece, is one of the recognized systems of medicine in India. They're regarded as the safest medical systems. Still with the scientific morality everything is rejected or accepted in the light of available clinical data only. Hence, to produce pharmacovigilance, program for ASU medicines come essential for giving them credibility. Pharmacovigilance is an important tool to assay the medicine effect particularly its side effects, if any. To raise awareness among health care professionals about the pharmacovigilance of Unani medicines and to explore different ways of making it operationally better among health care professionals and inspire a culture of reporting regularly to the separate addition or advanced centers. In order to achieve functional capability in the enhancement of pharmacovigilance for Unani drugs and for the best practice model for Unani medicines, a methodical analysis of the areas to be concentrated upon and the challenges ahead, starting from proper nomenclature of Unani medicines, civilization, procurement, drying, transportation, processing, labelling and administering was accepted. All the critical areas were related and an understanding for the recognition and management of adverse responses due to Unani medicines was developed. This paper gives brief conception of pharmacovigilance, and reporting of ADR of Unani Medicines.

KEYWORDS: Pharmacovigilance, Unani system of medicine, Therapy, Dietotherapy, Unani treatment Unani drugs.